| Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis C McBain, TA Lawrie, E Rogozińska, A Kernohan, T Robinson, S Jefferies Cochrane Database of Systematic Reviews 1, 2021 | 86 | 2021 |
| The impact of New Labour’s English health inequalities strategy on geographical inequalities in infant mortality: a time-trend analysis T Robinson, H Brown, PD Norman, LK Fraser, B Barr, C Bambra J Epidemiol Community Health 73 (6), 564-568, 2019 | 63 | 2019 |
| Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis C Hanna, TA Lawrie, E Rogozińska, A Kernohan, S Jefferies, H Bulbeck, ... Cochrane Database of Systematic Reviews 3, 2020 | 61 | 2020 |
| An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England K Thomson, R Berry, T Robinson, H Brown, C Bambra, A Todd BMC Public Health 20 (1), 1-9, 2020 | 34 | 2020 |
| Prognostic value of test (s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with … A McAleenan, C Kelly, F Spiga, A Kernohan, HY Cheng, S Dawson, ... Cochrane Database of Systematic Reviews, 2021 | 28 | 2021 |
| Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: a comprehensive meta‐analysis based on a Cochrane Systematic Review S Brandner, A McAleenan, HE Jones, A Kernohan, T Robinson, L Schmidt, ... Neuropathology and Applied Neurobiology, 2021 | 16 | 2021 |
| Health for Wealth: Building a Healthier Northern Powerhouse for UK Productivity C Bambra, L Munford, H Brown, A Wilding, T Robinson, P Holland, B Barr, ... | 16 | 2018 |
| Measuring Weight Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test Re-Test Reliability of the WAItE Y Oluboyede, T Robinson Value in Health 22 (3), 348-354, 2019 | 15 | 2019 |
| Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma A McAleenan, HE Jones, A Kernohan, T Robinson, L Schmidt, S Dawson, ... Cochrane Database of Systematic Reviews, 2022 | 13 | 2022 |
| Estimating CHU-9D Utility Scores from the WAItE: A Mapping Algorithm for Economic Evaluation T Robinson, Y Oluboyede Value in Health 22 (2), 239-246, 2019 | 11 | 2019 |
| Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT. M Nugent, V Bryant, C Butcher, H Fisher, S Gill, R Goranova, S Hiu, ... Health Technology Assessment (Winchester, England) 26 (46), 1, 2022 | 7 | 2022 |
| Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT L Robinson, M Poole, E McLellan, R Lee, S Amador, N Bhattarai, A Bryant, ... | 7 | 2020 |
| Differences in health-related quality of life between the Roma community and the general population in Romania T Robinson, Y Oluboyede, L Vale, E Olariu Journal of Patient-Reported Outcomes 6 (1), 127, 2022 | 6 | 2022 |
| Interventions to reduce the time to diagnosis of brain tumours R Grant, T Dowswell, E Tomlinson, PM Brennan, FM Walter, ... Cochrane Database of Systematic Reviews 9, 2020 | 4 | 2020 |
| Exploring views of members of the public and policymakers on the acceptability of population level dietary and active-travel policies: a qualitative study Z Toumpakari, S Valerino-Perea, K Willis, J Adams, M White, M Vasiljevic, ... International Journal of Behavioural Nutrition and Physical Activity, 2023 | 3 | 2023 |
| Developing a preference-based measure for weight-specific health-related quality of life in adolescence: the WAItE UK valuation study protocol T Robinson, S Hill, Y Oluboyede BMJ open 11 (11), e054203, 2021 | 3 | 2021 |
| Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review … G Orozco Leal, N Armstrong, A Kernohan, C Ahmadu, D Coughlan, ... PharmacoEconomics 41 (7), 741-750, 2023 | 2 | 2023 |
| Evaluating high-cost technologies–no need to throw the baby out with the bathwater GS Sagoo, T Robinson, D Coughlan, N Meader, S Rice, L Vale Expert Review of Pharmacoeconomics & Outcomes Research 23 (10), 1177-1183, 2023 | 1 | 2023 |
| Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer … G Orozco-Leal, EE Johnson, S Hosseinijebeli, T Robinson, T Homer, ... PharmacoEconomics 42 (2), 133-136, 2024 | | 2024 |
| Valuing selected WAItE health states using the Time Trade-Off methodology: findings from an online interviewer-assisted remote survey T Robinson, S Hill, G Orozco-Leal, A Kernohan, W King, Y Oluboyede Journal of Patient-Reported Outcomes 8 (1), 6, 2024 | | 2024 |
Dr Ashleigh KernohanSenior Research Associate, Newcastle UniversityVerified email at newcastle.ac.uk
